Myriad Genetics (MYGN) Stock: Buy, Sell, or Hold?
MYGN - Myriad Genetics Inc
$4.31
0.11 (2.62%)
â˛
5d:
-5.07%
30d:
+28.27%
90d:
-26.45%
WAIT
LOW Confidence
Analysis Updated: Oct 9, 2026 12:00 AM ET
Earnings: Nov 02, 2026
22d
Get Alerted When MYGN Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
âšī¸ NEUTRAL: MYGN is fairly priced but lacks strong directional signals. At 0% expected growth, valuation appears cheap. Wait for clearer setup or better entry on dips.
âšī¸ NEUTRAL: MYGN is fairly priced but lacks strong directional signals. At 0% expected growth, valuation appears cheap. Wait for clearer setup or better entry on dips.
In-depth Analysis How we analyze
Valuation Analysis: MYGN is currently trading at $4.31, which is considered slightly high relative to its 30-day fair value range of $3.41 to $4.32. From a valuation perspective, the stock is trading at a discount (Forward PE: -7.3) compared to its historical average (50.8). At these levels, the market is pricing in 0% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.
Technical Outlook: Technically, MYGN is in a downtrend. Immediate support is located at $4.05, while resistance sits at $4.83.
Market Sentiment: MYGN scores 29/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, MYGN is in a downtrend. Immediate support is located at $4.05, while resistance sits at $4.83.
Market Sentiment: MYGN scores 29/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
SLIGHTLY HIGH
Historical Trading Range
$3.41 -
$4.32
Company Quality Score
43/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
40.5%
Protect Your Profits
Holding MYGN? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BEARISH: Weak technical setup (29/100)
- BULLISH: High volume confirmation
- BEARISH: Trading above Wall St target ($4.05)
- BULLISH: Market expects only 0% annual growth - appears undervalued
- WARNING: Composite score 43/100 in the bottom quintile â this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$3.41 -
$4.32
Current vs Trading Range
SLIGHTLY HIGH
Support & Resistance Levels
Support Level
$4.05
Resistance Level
$4.83
Current Trend
Downtrend
Technical data as of
Oct 9, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-7.31
Wall Street Target
$4.05
(-6.0%)
Revenue Growth (YoY)
-10.5%
Profit Margin
-14.0%
PE vs Historical
-7.3 vs 50.8
CHEAP
Share & Embed Analysis
Last updated: October 10, 2026 6:34 PM ET
Data refreshes hourly during market hours. Next update: 7:34 PM
Data refreshes hourly during market hours. Next update: 7:34 PM
đĨ Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is MYGN showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Diagnostics & Research Stocks
Top-rated stocks in Diagnostics & Research by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
TMO
Thermo Fisher ScientificâĻ |
STRONG BUY
28 analysts |
$653 | 51 HOLD |
|
EXAS
EXACT Sciences CorporatiâĻ |
STRONG BUY
26 analysts |
$106 | 52 HOLD |
|
DHR
Danaher Corporation |
STRONG BUY
25 analysts |
$235 | 55 HOLD |
|
IQV
IQVIA Holdings Inc |
STRONG BUY
22 analysts |
$289 | 59 HOLD |
|
GH
Guardant Health Inc |
STRONG BUY
23 analysts |
$196 | 44 HOLD |
Advanced MYGN Option Strategies
Professional options setups generated by AI based on today's MYGN price and gamma walls.
